HEADER CYTOKINE 28-DEC-22 8C3U TITLE CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH A LOW MOLECULAR TITLE 2 WEIGHT ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 BETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FAB LIGHT-CHAIN; COMPND 5 SYNONYM: IL-1 BETA,CATABOLIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL1B, IL1F2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL23 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS BETA TREFOIL FOLD; SECRETED, CYTOKINE EXPDTA X-RAY DIFFRACTION AUTHOR J.-M.RONDEAU,S.LEHMANN,E.KOCH REVDAT 2 27-MAR-24 8C3U 1 JRNL REVDAT 1 13-SEP-23 8C3U 0 JRNL AUTH U.HOMMEL,K.HURTH,J.M.RONDEAU,A.VULPETTI,D.OSTERMEIER, JRNL AUTH 2 A.BOETTCHER,J.P.BRADY,M.HEDIGER,S.LEHMANN,E.KOCH, JRNL AUTH 3 A.BLECHSCHMIDT,R.YAMAMOTO,V.TUNDO DOTTORELLO, JRNL AUTH 4 S.HAENNI-HOLZINGER,C.KAISER,P.LEHR,A.LINGEL,L.MUREDDU, JRNL AUTH 5 C.SCHLEBERGER,J.BLANK,P.RAMAGE,F.FREULER,J.EDER,F.BORNANCIN JRNL TITL DISCOVERY OF A SELECTIVE AND BIOLOGICALLY ACTIVE JRNL TITL 2 LOW-MOLECULAR WEIGHT ANTAGONIST OF HUMAN INTERLEUKIN-1 BETA. JRNL REF NAT COMMUN V. 14 5497 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37679328 JRNL DOI 10.1038/S41467-023-41190-0 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 24237 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 1185 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.78 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 485 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3140 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 464 REMARK 3 BIN R VALUE (WORKING SET) : 0.3165 REMARK 3 BIN FREE R VALUE : 0.2574 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2424 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 202 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.37120 REMARK 3 B22 (A**2) : -1.29490 REMARK 3 B33 (A**2) : 5.66620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.57360 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.187 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.159 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.182 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.157 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2548 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3442 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 908 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 430 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2548 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 312 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2015 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -15.8303 -8.3104 -55.8763 REMARK 3 T TENSOR REMARK 3 T11: -0.0580 T22: 0.0362 REMARK 3 T33: -0.1303 T12: -0.0048 REMARK 3 T13: -0.0088 T23: 0.0297 REMARK 3 L TENSOR REMARK 3 L11: 1.8143 L22: 2.1247 REMARK 3 L33: 2.7934 L12: 0.5604 REMARK 3 L13: -0.2736 L23: 0.9977 REMARK 3 S TENSOR REMARK 3 S11: 0.0623 S12: -0.3626 S13: -0.0758 REMARK 3 S21: -0.1675 S22: -0.1844 S23: -0.0252 REMARK 3 S31: -0.1097 S32: 0.0396 S33: 0.1221 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -8.3895 -12.5483 -24.7253 REMARK 3 T TENSOR REMARK 3 T11: -0.0113 T22: -0.0674 REMARK 3 T33: -0.0427 T12: 0.0008 REMARK 3 T13: -0.0043 T23: -0.0067 REMARK 3 L TENSOR REMARK 3 L11: 4.1834 L22: 1.0599 REMARK 3 L33: 1.4432 L12: -0.4678 REMARK 3 L13: 0.8131 L23: -0.0560 REMARK 3 S TENSOR REMARK 3 S11: -0.0426 S12: 0.2346 S13: -0.1393 REMARK 3 S21: 0.0541 S22: 0.0562 S23: 0.0289 REMARK 3 S31: 0.0817 S32: 0.0782 S33: -0.0135 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8C3U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1292127718. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000036 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24314 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.945 REMARK 200 RESOLUTION RANGE LOW (A) : 50.741 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 2.03900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2I1B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.01M SODIUM CITRATE, 33% PEG 6,000, REMARK 280 PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.04250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 153 REMARK 465 SER B 153 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 108 -6.52 77.66 REMARK 500 ASN B 107 -132.90 61.08 REMARK 500 REMARK 500 REMARK: NULL DBREF 8C3U A 1 153 UNP P01584 IL1B_HUMAN 117 269 DBREF 8C3U B 1 153 UNP P01584 IL1B_HUMAN 117 269 SEQRES 1 A 153 ALA PRO VAL ARG SER LEU ASN CYS THR LEU ARG ASP SER SEQRES 2 A 153 GLN GLN LYS SER LEU VAL MET SER GLY PRO TYR GLU LEU SEQRES 3 A 153 LYS ALA LEU HIS LEU GLN GLY GLN ASP MET GLU GLN GLN SEQRES 4 A 153 VAL VAL PHE SER MET SER PHE VAL GLN GLY GLU GLU SER SEQRES 5 A 153 ASN ASP LYS ILE PRO VAL ALA LEU GLY LEU LYS GLU LYS SEQRES 6 A 153 ASN LEU TYR LEU SER CYS VAL LEU LYS ASP ASP LYS PRO SEQRES 7 A 153 THR LEU GLN LEU GLU SER VAL ASP PRO LYS ASN TYR PRO SEQRES 8 A 153 LYS LYS LYS MET GLU LYS ARG PHE VAL PHE ASN LYS ILE SEQRES 9 A 153 GLU ILE ASN ASN LYS LEU GLU PHE GLU SER ALA GLN PHE SEQRES 10 A 153 PRO ASN TRP TYR ILE SER THR SER GLN ALA GLU ASN MET SEQRES 11 A 153 PRO VAL PHE LEU GLY GLY THR LYS GLY GLY GLN ASP ILE SEQRES 12 A 153 THR ASP PHE THR MET GLN PHE VAL SER SER SEQRES 1 B 153 ALA PRO VAL ARG SER LEU ASN CYS THR LEU ARG ASP SER SEQRES 2 B 153 GLN GLN LYS SER LEU VAL MET SER GLY PRO TYR GLU LEU SEQRES 3 B 153 LYS ALA LEU HIS LEU GLN GLY GLN ASP MET GLU GLN GLN SEQRES 4 B 153 VAL VAL PHE SER MET SER PHE VAL GLN GLY GLU GLU SER SEQRES 5 B 153 ASN ASP LYS ILE PRO VAL ALA LEU GLY LEU LYS GLU LYS SEQRES 6 B 153 ASN LEU TYR LEU SER CYS VAL LEU LYS ASP ASP LYS PRO SEQRES 7 B 153 THR LEU GLN LEU GLU SER VAL ASP PRO LYS ASN TYR PRO SEQRES 8 B 153 LYS LYS LYS MET GLU LYS ARG PHE VAL PHE ASN LYS ILE SEQRES 9 B 153 GLU ILE ASN ASN LYS LEU GLU PHE GLU SER ALA GLN PHE SEQRES 10 B 153 PRO ASN TRP TYR ILE SER THR SER GLN ALA GLU ASN MET SEQRES 11 B 153 PRO VAL PHE LEU GLY GLY THR LYS GLY GLY GLN ASP ILE SEQRES 12 B 153 THR ASP PHE THR MET GLN PHE VAL SER SER HET T9C A 201 35 HET T9C B 201 35 HETNAM T9C (S)-4'-HYDROXY-3'-(6-METHYL-2-OXO-3-(1H-PYRAZOL-4-YL) HETNAM 2 T9C INDOLIN-3-YL)-[1,1'-BIPHENYL]-2,4-DICARBOXYLIC ACID HETSYN T9C 4-[3-[(3S)-6-METHYL-2-OXIDANYLIDENE-3-(1H-PYRAZOL-4- HETSYN 2 T9C YL)-1H-INDOL-3-YL]-4-OXIDANYL-PHENYL]BENZENE-1,3- HETSYN 3 T9C DICARBOXYLIC ACID FORMUL 3 T9C 2(C26 H19 N3 O6) FORMUL 5 HOH *202(H2 O) HELIX 1 AA1 GLN A 32 GLN A 39 5 8 HELIX 2 AA2 ASP A 86 TYR A 90 5 5 HELIX 3 AA3 GLU A 96 ARG A 98 5 3 HELIX 4 AA4 GLN B 32 GLN B 39 5 8 HELIX 5 AA5 ASP B 86 TYR B 90 5 5 HELIX 6 AA6 GLU B 96 ARG B 98 5 3 SHEET 1 AA1 9 LYS A 77 SER A 84 0 SHEET 2 AA1 9 LEU A 67 LYS A 74 -1 N SER A 70 O GLN A 81 SHEET 3 AA1 9 LYS A 55 LEU A 62 -1 N LEU A 62 O LEU A 67 SHEET 4 AA1 9 VAL A 100 ILE A 106 -1 O PHE A 101 N VAL A 58 SHEET 5 AA1 9 LYS A 109 SER A 114 -1 O GLU A 113 N ASN A 102 SHEET 6 AA1 9 PHE A 146 SER A 152 -1 O PHE A 146 N LEU A 110 SHEET 7 AA1 9 VAL A 3 ASP A 12 -1 N ARG A 11 O THR A 147 SHEET 8 AA1 9 PHE A 42 VAL A 47 -1 O PHE A 42 N CYS A 8 SHEET 9 AA1 9 LYS A 55 LEU A 62 -1 O GLY A 61 N SER A 43 SHEET 1 AA2 3 SER A 17 MET A 20 0 SHEET 2 AA2 3 LEU A 26 LEU A 29 -1 O LEU A 29 N SER A 17 SHEET 3 AA2 3 MET A 130 PRO A 131 -1 O MET A 130 N ALA A 28 SHEET 1 AA3 2 TYR A 121 SER A 123 0 SHEET 2 AA3 2 PHE A 133 GLY A 135 -1 O GLY A 135 N TYR A 121 SHEET 1 AA4 9 LYS B 77 SER B 84 0 SHEET 2 AA4 9 LEU B 67 LYS B 74 -1 N SER B 70 O GLN B 81 SHEET 3 AA4 9 LYS B 55 LEU B 62 -1 N LEU B 62 O LEU B 67 SHEET 4 AA4 9 VAL B 100 ILE B 106 -1 O PHE B 101 N VAL B 58 SHEET 5 AA4 9 LYS B 109 SER B 114 -1 O GLU B 113 N ASN B 102 SHEET 6 AA4 9 PHE B 146 PHE B 150 -1 O PHE B 146 N LEU B 110 SHEET 7 AA4 9 VAL B 3 ASP B 12 -1 N ARG B 11 O THR B 147 SHEET 8 AA4 9 PHE B 42 VAL B 47 -1 O PHE B 42 N CYS B 8 SHEET 9 AA4 9 LYS B 55 LEU B 62 -1 O GLY B 61 N SER B 43 SHEET 1 AA5 3 SER B 17 MET B 20 0 SHEET 2 AA5 3 LEU B 26 LEU B 29 -1 O LEU B 29 N SER B 17 SHEET 3 AA5 3 MET B 130 PRO B 131 -1 O MET B 130 N ALA B 28 SHEET 1 AA6 2 TYR B 121 SER B 123 0 SHEET 2 AA6 2 PHE B 133 GLY B 135 -1 O GLY B 135 N TYR B 121 CISPEP 1 TYR A 90 PRO A 91 0 -1.78 CISPEP 2 TYR B 90 PRO B 91 0 2.81 CRYST1 56.168 60.085 55.877 90.00 114.76 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017804 0.000000 0.008211 0.00000 SCALE2 0.000000 0.016643 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019708 0.00000